Illinois biologics regulations.

Who may administer PRP, exosomes and stem cells in Illinois, and which agencies to check.

A physician at a desk reading regulatory documents

Who may administer biologics in Illinois?

In Illinois, biologic treatments such as stem cell therapy should be administered by licensed medical providers. Typically, this includes medical doctors (MDs), doctors of osteopathic medicine (DOs), and advanced practice registered nurses (APRNs) operating within their licensed scope and under physician supervision.

Official sources

Illinois compliance guide.

FDA Compliance

In the U.S., biologics are regulated by the Food and Drug Administration (FDA), specifically under the Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P) framework. Clinics offering biologics, such as stem cell therapies, should ensure compliance with the FDA's requirements to prevent potential enforcement actions. For more information, refer to FDA’s regulations in 21 CFR Part 1271, which set standards for registration, donor eligibility, and handling procedures.

Illinois State Regulations

Compliance with Illinois state regulations is essential for clinics offering biologic treatments. The Illinois Department of Public Health (IDPH) oversees healthcare provider requirements and patient safety standards. Specific details on Illinois healthcare regulations can be accessed via the Illinois Department of Public Health website. Clinics should stay informed of any state-specific laws that may impact their practice, particularly in areas of licensure and treatment protocols.

Provider Qualifications

In Illinois, biologic treatments such as stem cell therapy should be administered by licensed medical providers. Typically, this includes medical doctors (MDs), doctors of osteopathic medicine (DOs), and advanced practice registered nurses (APRNs) operating within their licensed scope and under physician supervision. The Illinois Department of Financial and Professional Regulation provides resources on licensure requirements for healthcare professionals.

Patient Informed Consent

Patient consent is a critical component of compliance. Illinois providers must inform patients about the potential risks, benefits, and alternative treatments associated with biologics, especially given the experimental nature of certain therapies. Detailed consent forms should include disclaimers noting that some biologic therapies may be unproven and are not FDA-approved.

Pre-Treatment and Post-Treatment Protocols

Developing standard pre-treatment and post-treatment protocols is recommended for safety and consistency in patient care. Protocols should be evidence-based, ensuring patients are properly prepared and monitored throughout treatment.

Standard Operating Procedures (SOPs)

Establishing Standard Operating Procedures (SOPs) helps clinics maintain consistent compliance practices. SOPs should include donor eligibility screenings, product handling procedures, and patient safety checks.

Medical Liability Insurance

Medical liability insurance is advisable for any clinic offering biologic treatments to cover potential risks. Clinics should verify that their policy includes coverage for biologics and stem cell therapies.

Marketing Compliance

Illinois clinics should ensure that marketing materials accurately represent biologic treatments and comply with both FDA and Illinois advertising regulations. Avoid unverified claims about the efficacy of treatments to prevent potential regulatory issues.

This guide is a general summary to help clinics understand compliance requirements for biologics in Illinois. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.

Illinois: common questions.

Who can administer stem cells, PRP and exosomes in Illinois?
In Illinois, biologic treatments such as stem cell therapy should be administered by licensed medical providers. Typically, this includes medical doctors (MDs), doctors of osteopathic medicine (DOs), and advanced practice registered nurses (APRNs) operating within their licensed scope and under physician supervision. This is a general summary, not legal advice. Confirm with the state board.
Are stem cell and exosome therapies FDA-approved in Illinois?
FDA rules are federal, so they apply in Illinois as everywhere else. Exosome and stem cell therapies are not FDA-approved for therapeutic use, and PRP applications are considered off-label.
Do I need an IRB-approved study to offer biologics in Illinois?
Investigational treatment belongs inside a reviewed study with proper informed consent. IRB review is not FDA authorisation: culture-expanded and other more-than-minimally-manipulated cell products generally need an IND before use in people.
How do I start offering biologics in Illinois?
Start with the live webinar, then a discovery call and live training. After that we verify your Illinois licence, protocol, product sourcing, consent process and advertising before you are listed for patient inquiries.

Practising in Illinois? Start with the webinar.

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.